Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
CA 2379336 A1 · Owner: Charles, Marie-Helene · Inventors: Santoro, Lyse; Kolbe, Hanno; Roecklin, Dominique
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the use of at least one polypeptide comprising a protein fragment to obtain a diagnostic prognostic, prophylactic or therapeutic composition for detecting preventing or treating a pathological condition associated with a degenerative and/or neurological and/or autoimmune disease said protein being selected among the proteins whereof the peptide sequence in native state corresponds to SEQ ID No 1 SEQ ID No 2, SEQ ID No 3, SEQ ID No 4, SEQ ID No 5 SEQ ID No 6, SEQ ID No 7, SEQ ID No 8, SEQ ID No 9 SEQ ID No 10, SEQ ID No 11, SEQ ID No 12 SEQ ID No 13, SEQ ID No 14, SEQ ID No 15 SEQ ID No 16, SEQ ID No 17, SEQ ID No 18 SEQ ID No 19, SEQ ID No 20, SEQ ID No 21 SEQ ID No …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.